Delta-Fly Pharma(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証GRT | 医薬品 | 4598/ - | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2020/07/22 | 日証協 | 464,500株 | +2.29% | 13,900株 | -84.91% | 532,683株 | -5.26% | 39,310株 | -65.06% |
2020/07/17 | 日証協 | 454,100株 | -1.56% | 92,100株 | +36.65% | 562,261株 | +1.31% | 112,515株 | +37.01% |
2020/07/10 | 日証協 | 461,300株 | +7.18% | 67,400株 | -27.21% | 554,964株 | +3.76% | 82,121株 | +28.7% |
2020/07/03 | 日証協 | 430,400株 | -3.74% | 92,600株 | +68.98% | 534,837株 | +0.57% | 63,806株 | -15.62% |
2020/06/26 | 日証協 | 447,100株 | -2.44% | 54,800株 | -58.2% | 531,822株 | +0.32% | 75,615株 | -51.06% |
2020/06/12 | 日証協 | 382,100株 | +8.98% | 86,200株 | -38.16% | 404,207株 | +15.21% | 81,500株 | -50.55% |
2020/06/05 | 日証協 | 350,600株 | +1.07% | 139,400株 | +138.7% | 350,832株 | +6.4% | 164,806株 | +164.54% |
2020/05/29 | 日証協 | 346,900株 | +5.5% | 58,400株 | -68.12% | 329,716株 | +4.37% | 62,300株 | -30.32% |
2020/05/22 | 日証協 | 328,800株 | +46.79% | 183,200株 | +29.01% | 315,916株 | +28.52% | 89,415株 | -10.94% |
2020/05/15 | 日証協 | 224,000株 | -19.54% | 142,000株 | +53.18% | 245,816株 | -14.12% | 100,400株 | +152.9% |
2020/05/08 | 日証協 | 278,400株 | +36% | 92,700株 | -69.88% | 286,216株 | +19.2% | 39,700株 | -79.83% |
2020/05/01 | 日証協 | 204,700株 | +128.72% | 307,800株 | +391.69% | 240,116株 | +77.53% | 196,800株 | +109.56% |
2020/04/24 | 日証協 | 89,500株 | +40.72% | 62,600株 | +343.97% | 135,252株 | +14.96% | 93,910株 | +396.88% |
2020/04/17 | 日証協 | 63,600株 | +9.09% | 14,100株 | +187.76% | 117,652株 | +4.79% | 18,900株 | +170% |
2020/04/10 | 日証協 | 58,300株 | -0.17% | 4,900株 | -20.97% | 112,275株 | -0.62% | 7,000株 | -43.09% |
2020/04/03 | 日証協 | 58,400株 | +2.1% | 6,200株 | -45.13% | 112,975株 | +8.87% | 12,300株 | -70.8% |
2020/03/27 | 日証協 | 57,200株 | +5.15% | 11,300株 | +264.52% | 103,775株 | +6.49% | 42,123株 | +16.99% |
2020/03/19 | 日証協 | 54,400株 | +6.25% | 3,100株 | -43.64% | 97,447株 | +6.54% | 36,005株 | +81.84% |
2020/03/13 | 日証協 | 51,200株 | -8.08% | 5,500株 | -60.71% | 91,464株 | +11.18% | 19,800株 | +18.55% |
※株式分割は考慮していませんのでご注意ください。
Page Top